Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene Receives 2021 BioTech Breakthrough Award

BEVERLY, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
November 01, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene Finalizes Design of Pneumonia Panel

BEVERLY, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
October 29, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene Completes First Stage of U.S. ARMY DEVCOM Agreement

BEVERLY, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
October 27, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene’s MiQLab™ System Selected to be a Best in Show Spotlight at the 47th Annual Industry Petcare Innovation Summit

BEVERLY, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
October 26, 2021 10:55 ET | Source: LexaGene Holdings Inc

LexaGene to Host Corporate Update on November 3

BEVERLY, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
October 25, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing

BEVERLY, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
October 07, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene’s Largest Study Validates Accuracy of its Veterinary Test Panel

Technology Accurately Identifies Pathogens and Predicts Antimicrobial Resistance In less than 30 years, drug resistant bacteria are predicted to kill 3 times more people on an annual basis than...
October 01, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene Expands Brand Awareness at Key Investor Conferences

BEVERLY, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...
September 30, 2021 07:45 ET | Source: LexaGene Holdings Inc

LexaGene Reports on Recent Veterinary Trade Shows

BEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...
September 17, 2021 16:00 ET | Source: LexaGene Holdings Inc

LexaGene Adopts Corporate Governance Charters and Policies

BEVERLY, Mass., Sept. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...